CT-ACL001

· CoreTissue BioEngineering Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT-ACL001, covering 2025-09-30 to 2025-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Obtain Safety and Effectiveness of CT-ACL001, a Regenerative Ligament Using Biological Tissue, in ACLR [NA]